Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Oct 14, 2026
TickeronGET DAILY SIGNALS
Sono-Tek (SOTK): Analyst Targets Suggest +19% Upside From Current Levels

Sono-Tek (SOTK): Analyst Targets Suggest +19% Upside From Current Levels

Key Takeaways

  • The central price target used here is $8.50, the arithmetic mean of the two analyst price targets currently tracked for the stock, which range from $7.00 to $10.00.
  • With shares at $7.12, the stock would need to rise roughly 19% to reach $8.50.
  • Sono-Tek Corporation (SOTK) is a micro-cap maker of ultrasonic coating systems, not an ETF, and its analyst coverage is thin—just two firms—so the target rests on a narrow base.
  • The strongest support comes from growing medical-device and clean-energy demand, a sizable order backlog, and a share price trading near its 52-week high.
  • The biggest risks are a very high valuation, slowing revenue growth expectations, and limited analyst conviction after a 2025 downgrade.

Understanding the Analyst Targets for SOTK

Sono-Tek Corporation (SOTK), founded in 1975 and headquartered in Milton, New York, designs and manufactures ultrasonic thin-film coating systems used in microelectronics and semiconductors, medical devices, alternative energy, industrial, and research applications. It is a true micro-cap, with a market capitalization near $112 million.

Analyst coverage is limited. According to S&P Global data cited by SOTK trackers, just two analysts currently publish price targets, and their estimates are unusually far apart—$7.00 on the low end and $10.00 on the high end. The arithmetic mean of those two figures is $8.50, which is the central target used in this article and implies roughly 19% upside from the last verified closing price of $7.12.

The wide range reflects genuine disagreement about the company's trajectory. Northland Capital Markets took a notably cautious turn, downgrading the shares to Market Perform in May 2025 and stepping aside while citing uncertainty about the second half of fiscal 2026. By contrast, Oak Ridge Financial has maintained a more constructive Buy stance, pointing to medical-device demand and higher-priced production systems as growth drivers. With only two voices, the "average analyst price target" should be read as a rough midpoint rather than a firm Wall Street consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Where SOTK Stands Today

Shares closed at $7.12 on October 13, 2026, near the top of a 52-week range of $3.40 to $7.48. Reaching $8.50 would require a move of about 19%, a substantial gain even for a volatile micro-cap, and it would take the stock above its 52-week high while remaining below its all-time closing high of $9.49 set in December 2021.

The path to the target depends heavily on whether the company can sustain order momentum and expand margins. Revenue over the trailing twelve months is about $21.4 million, with net income near $2.1 million and EPS (earnings per share) of $0.13. Growth has been modest, and analysts expect revenue to expand only slightly in the near term. That means any move toward $8.50 would likely depend more on multiple expansion and continued order wins than on a sharp acceleration in reported earnings.

Bullish Factors for Reaching the Target

  • Demand from medical-device and clean-energy customers, including a multi-million-dollar order for MediCoat coating systems announced for delivery beginning in 2026.
  • A healthy equipment-and-services backlog, which stood at roughly $7.5 million as of mid-2025, providing near-term revenue visibility.
  • A shift toward higher-priced, higher-volume production lines rather than one-off research tools, which could lift average selling prices and margins.
  • Strong recent share-price momentum—the stock has risen about 72% year to date—which can attract additional investor attention to a thinly covered name.

Key Risks to Consider

  • Valuation risk: the trailing P/E (price-to-earnings) ratio is above 50x, well above typical industrial-sector levels, leaving little room for disappointment.
  • Slow growth expectations: analysts forecast only modest revenue growth, and one estimate points to flat near-term expansion, which may not justify a higher multiple.
  • Thin coverage and mixed conviction, including Northland's 2025 downgrade over fiscal 2026 uncertainty.
  • Macro and policy sensitivity, particularly shifts in clean-energy subsidies and tariffs, which the company itself has flagged as affecting order timing.

Technical Outlook and Levels to Watch

The stock is trading just below its 52-week high of $7.48, which acts as the nearest resistance level. A sustained close above that area would be needed before the $8.50 target becomes the next major reference point, with the December 2021 all-time high of $9.49 above it. On the downside, the low $7.00 area and the psychologically significant $6.00 level are durable support zones to watch. The stock's very low beta—roughly 0.1—indicates it has historically moved largely independent of broader market swings.

Looking Ahead: What to Watch

Analyst price targets typically reflect a roughly 12-month research horizon, though the small number of covering firms means individual assumptions can vary meaningfully. Investors should watch the next quarterly earnings report and any guidance updates, new order announcements, backlog trends, and changes to the two active analyst targets. Because the stock is heavily tied to clean-energy policy and medical-device capital spending, macroeconomic conditions and any shifts in government subsidy or tariff policy also matter for the price forecast.

Final Assessment

Can Sono-Tek reach $8.50? The target is the average of the two available analyst price targets, which span a wide $7.00 to $10.00 range, so it represents a midpoint rather than a confident forecast. The required move of roughly 19% is substantial, and the stock would need to clear its 52-week high and hold elevated valuation multiples. Supporting the case are growing medical-device and clean-energy orders and strong recent momentum; working against it are a P/E above 50x, modest expected revenue growth, and thin, divided analyst coverage. Whether the target is reached will likely depend on continued order wins, margin improvement, and whether the company can convert its backlog into sustained earnings growth. No outcome is guaranteed, and the target should be viewed as a reference point rather than a prediction. From what I see, the setup warrants close monitoring of upcoming catalysts.

AI Daily Buy/Sell Signals in My Research Process

For traders monitoring whether SOTK can sustain momentum toward higher levels, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to traditional research. The platform uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use it to discover new opportunities, keep an eye on existing positions, and spot shifting trends more efficiently. I find it helpful for cross-checking momentum in names like this one.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SOTK

SOTK sees MACD Histogram crosses below signal line

SOTK saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SOTK as a result. In 74 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

SOTK moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SOTK crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for SOTK entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOTK advanced for three days, in 166 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

SOTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.279) is normal, around the industry mean (1.448). P/E Ratio (33.077) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (3.258) is also within normal values, averaging (32.028).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. SOTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was -9%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -24%. SVRE experienced the highest price growth at 119%, while ARAI experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was -46%. For the same stocks of the Industry, the average monthly volume growth was 115% and the average quarterly volume growth was 58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 50
Price Growth Rating: 62
SMR Rating: 78
Profit Risk Rating: 83
Seasonality Score: 7 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ElectronicEquipmentInstruments

Industry
N/A
Address
2012 Route 9W
Phone
+1 845 795-2020
Employees
89
Web
https://www.sono-tek.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.